effects [qlco]
progesterone, micronized [horm, phsu, strd]
Added [ftcn]
Non [ftcn]
Oral [spco]
Estradiol [horm, phsu, strd]
Lipids [lipd]
cardiovascular risk factor [dsyn]
Early [tmco]
Post-Menopause [orgf]
Clinical Trial [resa]
Background [cnce]
Attention [menp]
Draw [inpr]
effects [qlco]
ADD [mobd]
Progestins [horm, phsu, strd]
Estrogen [horm, phsu, strd]
Hormone Therapy [topp]
postmenopausal [tmco]
Women [popg]
prescribed [hlca]
Progestins [horm, phsu, strd]
Show [inpr]
To [qlco]
effects [qlco]
Estrogens [horm, phsu, strd]
Surrogate Markers [qlco]
Cardiovascular disease [dsyn]
Risk [qlco]
Progestins [horm, phsu, strd]
High [qlco]
Androgen [horm, phsu]
activity [dora]
Interfere [qlco]
Lipid [lipd]
Profile [lbpr]
Glucose tolerance [phsf]
Affect [menp]
Mechanisms [ftcn]
Estrogen [horm, phsu, strd]
Induced [ftcn]
C-reactive protein [aapp, imft]
Stimulation [topp]
Recent [tmco]
Data [idcn]
Show [inpr]
derivatives [chvs]
Not [ftcn]
progesterone, micronized [horm, phsu, strd]
Increase [ftcn]
Risk [qlco]
Venous Thromboembolism [patf]
transdermal estrogen [horm, phsu, strd]
Users [humn]
Aim [idcn]
Present [qnco]
Study [mnob]
To [qlco]
Assess [acty]
effects [qlco]
Combine [mnob]
progesterone, micronized [horm, phsu, strd]
Non [ftcn]
Oral [spco]
estrogen therapy [topp]
Lipid [lipd]
Profile [lbpr]
cardiovascular risk factor [dsyn]
Sample [sbst]
Early [tmco]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
Clinical Trial [resa]
Including [ftcn]
Women [popg]
Receive [qlco]
Intranasal [spco]
mg day [qnco]
Two [qnco]
months [tmco]
Women [popg]
Receive [qlco]
Percutaneous [spco]
Beta [plnt]
Gel [bodm]
Three [qnco]
months [tmco]
Group [idcn]
Received [qlco]
Additional [ftcn]
mg day [qnco]
progesterone, micronized [horm, phsu, strd]
Vaginal route [ftcn]
days month [tmco]
P NOS [aapp, imft]
Outcome [ftcn]
Measure [qnco]
included [ftcn]
Body Weight [orga]
Waist Circumference [clna]
Body Mass Index [diap]
Lipid [lipd]
Profile [lbpr]
ultra [medd]
Sensitive [ftcn]
C-reactive protein [aapp, imft]
baseline [bodm]
P NOS [aapp, imft]
Portion [spco]
treatment [ftcn]
Result [ftcn]
Mean [qnco]
Age [orga]
Mean [qnco]
Time [tmco]
Menopause [phsf]
months [tmco]
participants [popg]
Overweight [sosy]
Hormone Therapy [topp]
Not [ftcn]
Change [ftcn]
Body Mass Index [diap]
P NOS [aapp, imft]
Not [ftcn]
Affect [menp]
Waist Circumference [clna]
weight [orga]
menopausal symptoms [sosy]
Improved [qlco]
Hormone Therapy [topp]
effects [qlco]
Intranasal [spco]
Percutaneous [spco]
Estradiol [horm, phsu, strd]
Similar [qlco]
Addition [ftcn]
Progesterone [horm, phsu, strd]
Overall [inpr]
Group [idcn]
Women [popg]
progesterone, micronized [horm, phsu, strd]
Not [ftcn]
Altered [ftcn]
Response [orga]
Blood Pressure [orgf]
Glucose [bacs, carb, phsu]
Insulin [aapp, horm, phsu]
Triglycerides [bacs, lipd]
ultra [medd]
Sensitive [ftcn]
C-reactive protein [aapp, imft]
progesterone, micronized [horm, phsu, strd]
Total Cholesterol [lbpr]
Decreased [qnco]
Progesterone [horm, phsu, strd]
Maintained [ftcn]
reduction [npop]
Level [qlco]
Similar [qlco]
baseline [bodm]
Lower [spco]
P NOS [aapp, imft]
baseline [bodm]
Conclusions [idcn]
Cyclic [tmco]
Short-term [tmco]
Exposure NOS [inpo]
Vaginal [bpoc]
progesterone, micronized [horm, phsu, strd]
Not [ftcn]
Altered [ftcn]
Metabolic [ftcn]
CARDIOVASCULAR [bdsy]
Effect [qlco]
Non [ftcn]
Oral [spco]
Early [tmco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
